<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101129617</journal-id>
<journal-id journal-id-type="pubmed-jr-id">30409</journal-id>
<journal-id journal-id-type="nlm-ta">Genes Brain Behav</journal-id>
<journal-id journal-id-type="iso-abbrev">Genes Brain Behav.</journal-id>
<journal-title-group>
<journal-title>Genes, brain, and behavior</journal-title>
</journal-title-group>
<issn pub-type="ppub">1601-1848</issn>
<issn pub-type="epub">1601-183X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26515765</article-id>
<article-id pub-id-type="pmc">4833497</article-id>
<article-id pub-id-type="doi">10.1111/gbb.12269</article-id>
<article-id pub-id-type="manuscript">CAMS5468</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Decoding the non-coding genome: elucidating genetic risk outside the coding genome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Barr</surname>
<given-names>C. L.</given-names>
</name>
<xref ref-type="aff" rid="A1">†</xref>
<xref ref-type="aff" rid="A2">‡</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Misener</surname>
<given-names>V. L.</given-names>
</name>
<xref ref-type="aff" rid="A1">†</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>†</label>Toronto Western Research Institute, University Health Network, Toronto, ON, Canada</aff>
<aff id="A2">
<label>‡</label>Program in Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Corresponding author: Dr C. L. Barr, The Toronto Western Research Institute, 60 Leonard Avenue, Krembil Discovery Tower 8KD-412, Toronto, Ontario M5T 2S8, Canada. <email>CBarr@uhnres.utoronto.ca</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>17</day>
<month>3</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>04</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>15</day>
<month>4</month>
<year>2016</year>
</pub-date>
<volume>15</volume>
<issue>1</issue>
<fpage>187</fpage>
<lpage>204</lpage>
<!--elocation-id from pubmed: 10.1111/gbb.12269-->
<abstract>
<p id="P1">Current evidence emerging from genome-wide association studies indicates that the genetic underpinnings of complex traits are likely attributable to genetic variation that changes gene expression, rather than (or in combination with) variation that changes protein-coding sequences. This is particularly compelling with respect to psychiatric disorders, as genetic changes in regulatory regions may result in differential transcriptional responses to developmental cues and environmental/psychosocial stressors. Until recently, however, the link between transcriptional regulation and psychiatric genetic risk has been understudied. Multiple obstacles have contributed to the paucity of research in this area, including challenges in identifying the positions of remote (distal from the promoter) regulatory elements (e.g. enhancers) and their target genes and the under-representation of neural cell types and brain tissues in epigenome projects – the availability of high-quality brain tissues for epigenetic and transcriptome profiling, particularly for the adolescent and developing brain, has been limited. Further challenges have arisen in the prediction and testing of the functional impact of DNA variation with respect to multiple aspects of transcriptional control, including regulatory-element interaction (e.g. between enhancers and promoters), transcription factor binding and DNA methylation. Further, the brain has uncommon DNA-methylation marks with unique genomic distributions not found in other tissues – current evidence suggests the involvement of non-CG methylation and 5-hydroxymethylation in neurodevelopmental processes but much remains unknown. We review here knowledge gaps as well as both technological and resource obstacles that will need to be overcome in order to elucidate the involvement of brain-relevant gene-regulatory variants in genetic risk for psychiatric disorders.</p>
</abstract>
<kwd-group>
<kwd>5-Hydroxymethylation</kwd>
<kwd>adolescent brain</kwd>
<kwd>enhancers</kwd>
<kwd>epigenetics</kwd>
<kwd>gene expression</kwd>
<kwd>gene regulation</kwd>
<kwd>methylation</kwd>
<kwd>non-CG methylation</kwd>
<kwd>non-coding RNA</kwd>
<kwd>psychiatric disorders</kwd>
<kwd>transcriptome</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>